23.10.2014 Views

final program.qxd - Parallels Plesk Panel

final program.qxd - Parallels Plesk Panel

final program.qxd - Parallels Plesk Panel

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

PP 5.8<br />

Management of Chronic hepatitis C with Pegylated Interferon and Ribavirin in a<br />

Prison Setting<br />

Sergio Sabbatani, Ruggero Giuliani, Roberto Manfredi<br />

Infectious Diseases, University of Bologna, Italy<br />

Introduction<br />

The elevated frequency of chronic HCV infection found among prison inmates, and the<br />

availability of improved pharmacological cure for this potentially life-threatening disorder,<br />

make the investigations conducted in this somewhat neglected area very promising, since<br />

only a few, open-label experiences are recorded until now.<br />

Patients, Methods, and Results<br />

In a serological survey conducted in the metropolitan prison of Bologna (Italy), HCV seroprevalence<br />

was recognised over 31% in the year 2003, so that a pilot feasibility study<br />

based on treatment with associated pegylated interferon plus ribavirin was initiated, after<br />

a careful counselling carried out by joined health care personnel of the correctional<br />

facility and Infectious Diseases consultants. Thirty-nine patients were enrolled, and<br />

despite expected drop-outs due to difficulty in maintaining the same counselling pressure<br />

during time, and the particularly unfavorable climatic conditions occurred in Summer 2003,<br />

a sustained virological response was obtained in 8 out of 21 patients who remained<br />

evaluable after the first three month of follow-up (38.1%), although we have to take into<br />

account that a relevant percentage of subjects (66.7%) were selected for therapy due to<br />

their favorable HCV genotypes (types 2 and 3).<br />

Conclusions<br />

Our preliminary experience shows that an intrinsecally complicated therapy such as the<br />

administation of pegylated interferon plus ribavirin, may be conducted with a<br />

proportionally elevated success rate also in a very unfavorable and unconfortable context,<br />

such as a prison, where only enforced counselling, active participation of internal health<br />

care operators, and patient's willingness maintaing an elevated level of co-operation and<br />

adherence, can overcome most of structural and relational difficulties typical of this<br />

difficult setting.<br />

POSTERS<br />

“ Focusing FIRST on PEOPLE “ 215 w w w . i s h e i d . c o m

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!